Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncation

Miou Zhou, Wei Xu, Guanghong Liao, Xiaoning Bi, Michel Baudry

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Many cellular events are involved in ischemic neuronal death, and it has been difficult to identify those that play a critical role in the cascade triggered by lack of oxygen and glucose, although it has been widely recognized that overactivation of glutamate receptors represents one of the initiating factors. Different glutamate receptor antagonists, especially those for N-methyl-d-aspartate (NMDA) receptors, have achieved significant success in animal models of hypoxia/ischemia; however, these antagonists have failed in clinical trials. We previously reported that calpain-mediated truncation of metabotropic glutamate receptor 1α (mGluR1α) played a critical role in excitotoxicity, and that a TAT-mGluR1 peptide consisting of a peptide surrounding the calpain cleavage site of mGluR1α and the peptide transduction domain of the transactivating regulatory protein (TAT) of HIV was neuroprotective against excitotoxicity. In the present study we tested the effect of this peptide in in vitro and in vivo models of neonatal hypoxia/ischemia. TAT-mGluR1 peptide prevented oxygen/glucose deprivation- (OGD) and hypoxia/ischemia- (H/I) induced neuronal death in cultured hippocampal slices and neonatal rats, respectively. TAT-mGluR1 blocked H/I-induced mGluR1α degradation but had no effect on H/I-induced spectrin degradation, suggesting that neuroprotection was due to prevention of calpain-mediated mGluR1α truncation and not to calpain inhibition. Our results therefore suggest that mGluR1α truncation plays a critical role in neonatal hypoxia/ischemia and that blockade of this event may prevent the activation of many downstream cytotoxic cascades. Compared to glutamate receptor antagonists and general calpain inhibitors, TAT-mGluR1 may have limited side effects.

Original languageEnglish (US)
Pages (from-to)75-82
Number of pages8
JournalExperimental Neurology
Volume218
Issue number1
DOIs
StatePublished - Jul 1 2009

Fingerprint

Brain Hypoxia-Ischemia
Calpain
Cell Death
Ischemia
Excitatory Amino Acid Antagonists
Peptides
Oxygen
Human Immunodeficiency Virus Proteins
metabotropic glutamate receptor type 1
Neuroprotection
Glucose
Spectrin
Glutamate Receptors
Hypoxia
Animal Models
Clinical Trials

Keywords

  • Calpain
  • Excitotoxicity
  • Hypoxia/ischemia
  • Metabotropic glutamate receptors
  • Oxygen/glucose deprivation
  • TAT-mGluR1

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncation. / Zhou, Miou; Xu, Wei; Liao, Guanghong; Bi, Xiaoning; Baudry, Michel.

In: Experimental Neurology, Vol. 218, No. 1, 01.07.2009, p. 75-82.

Research output: Contribution to journalArticle

@article{6b095960e7054dbab6dbf425ffaeed3c,
title = "Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncation",
abstract = "Many cellular events are involved in ischemic neuronal death, and it has been difficult to identify those that play a critical role in the cascade triggered by lack of oxygen and glucose, although it has been widely recognized that overactivation of glutamate receptors represents one of the initiating factors. Different glutamate receptor antagonists, especially those for N-methyl-d-aspartate (NMDA) receptors, have achieved significant success in animal models of hypoxia/ischemia; however, these antagonists have failed in clinical trials. We previously reported that calpain-mediated truncation of metabotropic glutamate receptor 1α (mGluR1α) played a critical role in excitotoxicity, and that a TAT-mGluR1 peptide consisting of a peptide surrounding the calpain cleavage site of mGluR1α and the peptide transduction domain of the transactivating regulatory protein (TAT) of HIV was neuroprotective against excitotoxicity. In the present study we tested the effect of this peptide in in vitro and in vivo models of neonatal hypoxia/ischemia. TAT-mGluR1 peptide prevented oxygen/glucose deprivation- (OGD) and hypoxia/ischemia- (H/I) induced neuronal death in cultured hippocampal slices and neonatal rats, respectively. TAT-mGluR1 blocked H/I-induced mGluR1α degradation but had no effect on H/I-induced spectrin degradation, suggesting that neuroprotection was due to prevention of calpain-mediated mGluR1α truncation and not to calpain inhibition. Our results therefore suggest that mGluR1α truncation plays a critical role in neonatal hypoxia/ischemia and that blockade of this event may prevent the activation of many downstream cytotoxic cascades. Compared to glutamate receptor antagonists and general calpain inhibitors, TAT-mGluR1 may have limited side effects.",
keywords = "Calpain, Excitotoxicity, Hypoxia/ischemia, Metabotropic glutamate receptors, Oxygen/glucose deprivation, TAT-mGluR1",
author = "Miou Zhou and Wei Xu and Guanghong Liao and Xiaoning Bi and Michel Baudry",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.expneurol.2009.04.006",
language = "English (US)",
volume = "218",
pages = "75--82",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncation

AU - Zhou, Miou

AU - Xu, Wei

AU - Liao, Guanghong

AU - Bi, Xiaoning

AU - Baudry, Michel

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Many cellular events are involved in ischemic neuronal death, and it has been difficult to identify those that play a critical role in the cascade triggered by lack of oxygen and glucose, although it has been widely recognized that overactivation of glutamate receptors represents one of the initiating factors. Different glutamate receptor antagonists, especially those for N-methyl-d-aspartate (NMDA) receptors, have achieved significant success in animal models of hypoxia/ischemia; however, these antagonists have failed in clinical trials. We previously reported that calpain-mediated truncation of metabotropic glutamate receptor 1α (mGluR1α) played a critical role in excitotoxicity, and that a TAT-mGluR1 peptide consisting of a peptide surrounding the calpain cleavage site of mGluR1α and the peptide transduction domain of the transactivating regulatory protein (TAT) of HIV was neuroprotective against excitotoxicity. In the present study we tested the effect of this peptide in in vitro and in vivo models of neonatal hypoxia/ischemia. TAT-mGluR1 peptide prevented oxygen/glucose deprivation- (OGD) and hypoxia/ischemia- (H/I) induced neuronal death in cultured hippocampal slices and neonatal rats, respectively. TAT-mGluR1 blocked H/I-induced mGluR1α degradation but had no effect on H/I-induced spectrin degradation, suggesting that neuroprotection was due to prevention of calpain-mediated mGluR1α truncation and not to calpain inhibition. Our results therefore suggest that mGluR1α truncation plays a critical role in neonatal hypoxia/ischemia and that blockade of this event may prevent the activation of many downstream cytotoxic cascades. Compared to glutamate receptor antagonists and general calpain inhibitors, TAT-mGluR1 may have limited side effects.

AB - Many cellular events are involved in ischemic neuronal death, and it has been difficult to identify those that play a critical role in the cascade triggered by lack of oxygen and glucose, although it has been widely recognized that overactivation of glutamate receptors represents one of the initiating factors. Different glutamate receptor antagonists, especially those for N-methyl-d-aspartate (NMDA) receptors, have achieved significant success in animal models of hypoxia/ischemia; however, these antagonists have failed in clinical trials. We previously reported that calpain-mediated truncation of metabotropic glutamate receptor 1α (mGluR1α) played a critical role in excitotoxicity, and that a TAT-mGluR1 peptide consisting of a peptide surrounding the calpain cleavage site of mGluR1α and the peptide transduction domain of the transactivating regulatory protein (TAT) of HIV was neuroprotective against excitotoxicity. In the present study we tested the effect of this peptide in in vitro and in vivo models of neonatal hypoxia/ischemia. TAT-mGluR1 peptide prevented oxygen/glucose deprivation- (OGD) and hypoxia/ischemia- (H/I) induced neuronal death in cultured hippocampal slices and neonatal rats, respectively. TAT-mGluR1 blocked H/I-induced mGluR1α degradation but had no effect on H/I-induced spectrin degradation, suggesting that neuroprotection was due to prevention of calpain-mediated mGluR1α truncation and not to calpain inhibition. Our results therefore suggest that mGluR1α truncation plays a critical role in neonatal hypoxia/ischemia and that blockade of this event may prevent the activation of many downstream cytotoxic cascades. Compared to glutamate receptor antagonists and general calpain inhibitors, TAT-mGluR1 may have limited side effects.

KW - Calpain

KW - Excitotoxicity

KW - Hypoxia/ischemia

KW - Metabotropic glutamate receptors

KW - Oxygen/glucose deprivation

KW - TAT-mGluR1

UR - http://www.scopus.com/inward/record.url?scp=67349277708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349277708&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2009.04.006

DO - 10.1016/j.expneurol.2009.04.006

M3 - Article

VL - 218

SP - 75

EP - 82

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -